Literature DB >> 14597640

Association between blood pressure and C-reactive protein levels in acute ischemic stroke.

Mario Di Napoli1, Francesca Papa.   

Abstract

Among patients with acute stroke, high blood pressure (BP) and higher levels of circulating C-reactive protein (CRP) at the entry are often associated with poor outcome, although the reason is unclear. If the link between BP and stroke outcome is indeed mediated by inflammatory response, one would expect to see positive associations between BP and CRP. In a prospective observational stroke data bank involving 535 first-ever ischemic stroke patients, we studied the association between BP and baseline concentrations of CRP within 24 hours after stroke onset. The association between BP components and the odds of having an elevated CRP level (> or =1.5 mg/dL) was assessed by logistic regression analysis. An increase in systolic BP (SBP), diastolic BP (DBP), mean arterial pressure (MAP), or pulse pressure (PP) was significantly associated with an increase in the odds of having an elevated CRP level, independent of other associated study factors. For each 10 mm Hg increase in SBP, DBP, MAP, or PP, the odds of having a high CRP level increased by 72% (P<0.0001), 10% (P<0.0001), 21% (P<0.0001), and 10% (P<0.0001), respectively. When the same model was rerun, adjusting for all considered BP components, only SBP significantly increased the odds of an elevated CRP level by 77% (P<0.0001). Increased SBP was significantly associated with elevated levels of circulating CRP in ischemic stroke patients. These findings support a possible role of acute hypertension after stroke as an inflammatory stimulus contributing to ischemic brain inflammation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14597640     DOI: 10.1161/01.HYP.0000100669.00771.6E

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  10 in total

1.  Significance of C-reactive protein in osteoarthritis and total knee arthroplasty outcomes.

Authors:  Jessica W Smith; Thomas B Martins; Evelyn Gopez; Troy Johnson; Harry R Hill; Thomas D Rosenberg
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-10       Impact factor: 5.346

Review 2.  Statins in hypertensive patients: potential explanations for the ASCOT-LLA study results.

Authors:  Luis Miguel Blanco-Colio; Julio I Osende; Jose Luis Martín-Ventura; José Tuñón; Jesús Egido
Journal:  Drugs       Date:  2004       Impact factor: 9.546

3.  Circulating beta amyloid protein is elevated in patients with acute ischemic stroke.

Authors:  P H Lee; O Y Bang; E M Hwang; J S Lee; U S Joo; I Mook-Jung; K Huh
Journal:  J Neural Transm (Vienna)       Date:  2005-01-31       Impact factor: 3.575

Review 4.  Inflammation, blood pressure, and stroke: an opportunity to target primary prevention?

Authors:  Mario Di Napoli; Francesca Papa
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

5.  Antihypertensive drugs and inflammation in acute ischemic stroke as a predictor factor of future cardiovascular mortality.

Authors:  Gulcin Benbir; Birsen Ince; Emre Kumral; Zeki Ongen; Hakan Kultursay; Lale Tokgozoglu; Ali Oto; Hasan Tuzun
Journal:  Inflammation       Date:  2012-02       Impact factor: 4.092

6.  Relationship Between the Serum Total Bilirubin and Inflammation in Patients With Psoriasis Vulgaris.

Authors:  Zhen-Xing Zhou; Jian-Kui Chen; Yan-Ying Hong; Ru Zhou; Dong-Mei Zhou; Li-Yun Sun; Wen-Li Qin; Tian-Cheng Wang
Journal:  J Clin Lab Anal       Date:  2016-04-07       Impact factor: 2.352

Review 7.  Inflammation in acute ischemic stroke and its relevance to stroke critical care.

Authors:  Hedley C A Emsley; Craig J Smith; Pippa J Tyrrell; Stephen J Hopkins
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

8.  Treatment with the cytochrome P450 ω-hydroxylase inhibitor HET0016 attenuates cerebrovascular inflammation, oxidative stress and improves vasomotor function in spontaneously hypertensive rats.

Authors:  Peter Toth; Anna Csiszar; Danuta Sosnowska; Zsuzsanna Tucsek; Peter Cseplo; Zsolt Springo; Stefano Tarantini; William E Sonntag; Zoltan Ungvari; Akos Koller
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

9.  Early changes in physiological variables after stroke.

Authors:  Andrew A Wong; Stephen J Read
Journal:  Ann Indian Acad Neurol       Date:  2008-10       Impact factor: 1.383

Review 10.  Systemic inflammation, blood pressure, and stroke outcome.

Authors:  Mario Di Napoli; Francesca Papa
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-03       Impact factor: 3.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.